Plasma arginine vasopressin concentrations in epileptics under monotherapy.
Plasma arginine vasopressin concentrations were determined by radio-immunoassay in 112 adult epileptics who were taking carbamazepine, phenytoin, primidone, or sodium valproate in long-term monotherapy, and in 19 controls. No significant difference was found between the groups, but some epileptics taking carbamazepine and primidone showed low values. Serum concentrations of carbamazepine did not correlate with the concentrations of plasma arginine vasopressin. In conclusion, there was no evidence of a stimulating effect of chronic carbamazepine medication or a special inhibiting effect of phenytoin on the release of vasopressin arginine from the posterior pituitary.
D000328:Adult; D000927:Anticonvulsants / Q000097:blood / Q000627:therapeutic use*; D001127:Arginine Vasopressin / Q000097:blood*; D002220:Carbamazepine / Q000627:therapeutic use; D004827:Epilepsy / Q000097:blood / Q000188:drug therapy*; D006801:Humans; D010672:Phenytoin / Q000627:therapeutic use; D011324:Primidone / Q000627:therapeutic use; D014635:Valproic Acid / Q000627:therapeutic use
D000927:Anticonvulsants; D001127:Arginine Vasopressin; D011324:Primidone; D002220:Carbamazepine; D014635:Valproic Acid; D010672:Phenytoin